Sonia Lorente Proloy Barua thank you for your kind help. I wanted to see if you know how we should rank the full-filled checklists according to this guideline. I did not find anything in the mentioned link.
If I were you, I would use total score and categorise them for ranking the included studies. For instance, score between 15-20, highest quality, 10-14, medium quality, and below 10, low quality. Thanks
Here is the link to the Joanna Briggs Institute Manual for Systematic Reviews. Chapter 3 may help you. Another way to evaluate the quality of studies is simply to mark the characteristics (i.e. yes, not or unclear) and describe if studies accomplish the most of properties or not, or which items are usually lacking in studies.
See the AMSTAR and the AMSTAR 2 for systematic reviews and meta-analysis.
This paper may be help you:
Kim, H., Choi, C., & Jo, E. (2020). A Methodological Quality Assessment of Meta-Analysis Studies in Dance Therapy Using AMSTAR and AMSTAR 2. Healthcare, 8.
Sonia Lorente, Thanks a lot. This is very helpful. I would like to ask whether this AMSTAR method is valid for Meta-Analysis too? or rather it is best suited for systemic reviews?
AMSTAR is used for SR but it is also applicable for meta-analysis, as the author's of the paper "A Methodological Quality Assessment of Meta-Analysis Studies in Dance Therapy Using AMSTAR and AMSTAR 2" suggested. This paper may help you.
For clinical trials (preferably RCTs), the gold standard is the Risk of Bias (ROB) tool of Cochrane collaboration. Currently, ROB 2 is available. For non-randomized trials, the ROBINS I (Risk Of Bias In Non-randomised Studies - of Interventions) is better. Please find the following links: